文献速递生殖医学

卵母细胞捐赠周期中自周期第7天起使用地屈孕酮的孕激素预处理卵巢刺激:一项纵向研究

Progestin primed ovarian stimulation using dydrogesterone from day 7 of the cycle onwards in oocyte donation cycles: a longitudinal study.
PubMed 文献 · Reprod Biomed Online · 2023-11-20

该回顾性纵向研究纳入64名卵母细胞捐赠者的128个周期,比较自周期第7天起使用地屈孕酮的孕激素预处理卵巢刺激(PPOS)方案与促性腺激素释放激素(GnRH)拮抗剂方案的结局。两种方案的获卵数(19.7±10.8 vs 19.2±8.3,P=0.5)和MII卵母细胞数(15.5±8.4 vs 16.2±7.0,P=0.19)相似。PPOS方案每周期药物总费用显著低于GnRH拮抗剂方案(898.3±169.9欧元 vs 1196.4±207.5欧元,P<0.001)。

要点

  • PPOS与GnRH拮抗剂方案的获卵数和MII卵母细胞数无显著差异。
  • PPOS方案每周期药物总费用显著低于GnRH拮抗剂方案。
  • 两种方案均未观察到提前排卵病例。

核心结论

  • 两种刺激方案的获卵数和MII卵母细胞数相当,PPOS方案较GnRH拮抗剂方案具有显著降低费用的优势。
  • 即使孕激素在刺激后期开始使用,也未观察到提前排卵病例。

研究设计与样本

  • 回顾性纵向研究,纳入64名卵母细胞捐赠者的128个周期。
  • 所有卵母细胞捐赠者在两个刺激周期中使用相同类型的促性腺激素和每日剂量。
  • 主要结局为获卵的卵丘-卵母细胞复合体(COC)数。

主要发现

  • PPOS方案与GnRH拮抗剂方案的获卵COC数分别为19.7±10.8与19.2±8.3(P=0.5)。
  • PPOS方案与GnRH拮抗剂方案的MII卵母细胞数分别为15.5±8.4与16.2±7.0(P=0.19)。
  • PPOS方案与GnRH拮抗剂方案的刺激持续时间分别为10.5±1.5天与10.8±1.5天(P=0.14)。
  • PPOS方案与GnRH拮抗剂方案的促性腺激素消耗量分别为2271.9±429.7 IU与2321.5±403.4 IU(P=0.2)。
  • PPOS方案与GnRH拮抗剂方案的每周期药物总费用分别为898.3±169.9欧元与1196.4±207.5欧元(P<0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Does a progestin-primed ovarian stimulation (PPOS) protocol with dydrogesterone from cycle day 7 yield similar outcomes compared with a gonadotrophin-releasing hormone (GnRH) antagonist protocol in the same oocyte donors? DESIGN: This retrospective longitudinal study included 128 cycles from 64 oocyte donors. All oocyte donors had the same type of gonadotrophin and daily dose in both stimulation cycles. The primary outcome was the number of cumulus-oocyte complexes (COC) retrieved. RESULTS: The number of COC retrieved (mean ± SD 19.7 ± 10.8 versus 19.2 ± 8.3; P = 0.5) and the number of metaphase II oocytes (15.5 ± 8.4 versus 16.2 ± 7.0; P = 0.19) were similar for the PPOS and GnRH antagonist protocols, respectively. The duration of stimulation (10.5 ± 1.5 days versus 10.8 ± 1.5 days; P = 0.14) and consumption of gonadotrophins (2271.9 ± 429.7 IU versus 2321.5 ± 403.4 IU; P = 0.2) were also comparable, without any cases of premature ovulation. Nevertheless, there was a significant difference in the total cost of medication per cycle: €898.3 ± 169.9 for the PPOS protocol versus €1196.4 ± 207.5 (P < 0.001) for the GnRH antagonist protocol. CONCLUSION: The number of oocytes retrieved and number of metaphase II oocytes were comparable in both stimulation protocols, with the advantage of significant cost reduction in favour of the PPOS protocol compared with the GnRH antagonist protocol. No cases of premature ovulation were observed, even when progestin was started later in the stimulation.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Hendrickx S, De Vos M, De Munck N, et al. Progestin primed ovarian stimulation using dydrogesterone from day 7 of the cycle onwards in oocyte donation cycles: a longitudinal study. Reprod Biomed Online. 2023. PMID: 38458058. doi:10.1016/j.rbmo.2023.103732

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。